Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Overview of attention for article published in "The Lancet Psychiatry", July 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#6 of 1,999)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 323 news outlets
blogs: 26 blogs
policy: 1 policy source
twitter: 267 tweeters
patent: 5 patents
facebook: 28 Facebook pages

wikipedia: 3 Wikipedia pages
googleplus: 3 Google+ users
reddit: 8 Redditors
f1000: 1 research highlight platform
video: 6 video uploaders

Citations

dimensions_citation: 408 Dimensions

Readers on

mendeley: 1337 Mendeley

Summary News Blogs Policy documents Twitter Patents Facebook Wikipedia Google+ Reddit Research highlights Video Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and…

Grant US-10954259-B1

United States of America

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and…

Grant US-10947257-B2

United States of America

COMPOSITIONS COMPRISING 5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR USE IN TREATING…

Application WO-2020169851-A1

World Intellectual Property Organisation (WIPO)

5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR TREATING DEPRESSION

Application WO-2020169850-A1

World Intellectual Property Organisation (WIPO)

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and…

Application US-10519175-B2

United States of America